Funding Trends in Japan Agency for Medical Research and Development (AMED): Focus on Psychiatry

Yuji Yamada; Megumi Haga; Yutaka Matsuoka

doi:10.31662/jmaj.2024-0391

Abstract

The Japan Agency for Medical Research and Development (AMED) was established in April 2015 as a funding agency for medical research and development. AMED has been striving to ensure the provision of state-of-the-art medical services and the advancement of a society characterized by health and longevity. Furthermore, AMED facilitates the seamless integration of research projects, spanning the spectrum from basic to applied research and practical applications. The current article presents an overview of the trends observed in awarded projects related to psychiatric disorders. Consequently, there was a considerable rise in the number of projects pertaining to medical devices, particularly within the domain of digital mental health. It is anticipated that an increased number of social implementation studies will obtain regulatory approval under the Pharmaceutical and Medical Device Act.

Content from these authors

JMA Journal applies the Creative Commons Attribution License to all works published by the journal. Anyone may download, reuse, copy, reprint, distribute, or modify articles published in the journal, if they cite the original authors and source. No permission is required from the publisher.
https://creativecommons.org/licenses/by/4.0/

Favorites & Alerts

Corresponding author

Register with J-STAGE for free!